VENUSS prognostic model for papillary kidney cancer
A recent study published in BMC Medicine this month investigates [...]
Hereditary kidney cancer – new syndromes
A recent review of the literature in European Urology summarises [...]
Mucinous tubular and spindle cell carcinoma
A recent study, published in Clinical Genitourinary Cancer, looked at [...]
Current perspectives on non-clear cell kidney cancer
The majority of kidney cancer (around 80%) is characterised as [...]
Clinical characteristics and genomic alterations associated with outcome in chromophobe RCC
A recent study by researchers in New York, USA, and [...]
Syntaxin 6: A potential biomarker for papillary renal cell carcinoma
A recent study published in Scientific Reports last month has [...]
Potential urine biomarkers for small renal masses
A recent study, published in the International Journal of Urology, [...]
ASCO GU 2019: Atezolizumab and bevacizumab in non-clear cell kidney cancer and sarcomatoid kidney cancer
Results from this trial for patients with non-clear cell renal [...]
ASCO GU 2019: When to obtain genetic testing for renal cell carcinoma
The following paper was presented at the American Society for [...]
ASCO GU 2019: Gemcitabine plus axitinib in patients with sarcomatoid renal cell carcinoma (RCC)
Results from this trial for sarcomatoid renal cell carcinoma (RCC) [...]
